Immune/infectious disease

1.
Jelte van der Vaart, Mart M. Lamers, Bart L. Haagmans, Hans Clevers. Advancing lung organoids for COVID-19 research. Disease Models & Mechanisms. 2021;14(6):dmm049060. doi:10.1242/dmm.049060
View Full Reference
1.
Alice Maria Giani, Shuibing Chen. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Research. 2021;53:102207. doi:10.1016/j.scr.2021.102207
View Full Reference
1.
Mart M. Lamers, Tim I. Breugem, Anna Z. Mykytyn, et al. Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7. 2021:2021.05.03.441080. doi:10.1101/2021.05.03.441080
View Full Reference
1.
Miriane de Oliveira, Maria T. De Sibio, Felipe A. S. Costa, Marna E. Sakalem. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19. ACS Biomaterials Science & Engineering. 2021;7(8):3487-3502. doi:10.1021/acsbiomaterials.1c00306
View Full Reference
1.
Bruna A. G. de Melo, Julia C. Benincasa, Elisa M. Cruz, Juliana Terzi Maricato, Marimelia A. Porcionatto. 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting. Biomedical Journal. 2021;44(1):31-42. doi:10.1016/j.bj.2020.11.009
View Full Reference
1.
Vivek V. Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet-Dessimoz, John D. McKinney. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. EMBO reports. 2021;22(6):e52744. doi:10.15252/embr.202152744
View Full Reference
1.
Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9
View Full Reference
1.
Lisa E. Wagar, Ameen Salahudeen, Christian M. Constantz, et al. Modeling human adaptive immune responses with tonsil organoids. Nature Medicine. 2021;27(1):125-135. doi:10.1038/s41591-020-01145-0
View Full Reference
1.
Joep Beumer, Maarten H. Geurts, Mart M. Lamers, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nature Communications. 2021;12(1):5498. doi:10.1038/s41467-021-25729-7
View Full Reference
1.
Abbas Shafiee, Lida Moradi, Mayasari Lim, Jason Brown. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Translational Medicine. 2021;10(1):27-38. doi:10.1002/sctm.20-0197
View Full Reference